For: | Fang P, Dong L, Luo JY, Wan XL, Du KX, Chai NL. Effects of motilin and ursodeoxycholic acid on gastrointestinal myoelectric activity of different origins in fasted rats. World J Gastroenterol 2004; 10(17): 2509-2513 [PMID: 15300894 DOI: 10.3748/wjg.v10.i17.2509] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i17/2509.htm |
Number | Citing Articles |
1 |
Mohsen Khosravi. Lewy body dementia: Ursodeoxycholic acid as a putative treatment for gastrointestinal dysfunction. European Journal of Translational Myology 2021; 31(2) doi: 10.4081/ejtm.2021.9876
|
2 |
Luo Xu, Xiangrong Sun, Inge Depoortere, Jiang Lu, Feifei Guo, Theo Louis Peeters. Effect of motilin on the discharge of rat hippocampal neurons responding to gastric distension and its potential mechanism. Peptides 2008; 29(4): 585 doi: 10.1016/j.peptides.2007.12.002
|
3 |
Gareth J. Sanger, John Broad, Brid Callaghan, John B. Furness. Gastrointestinal Pharmacology. Handbook of Experimental Pharmacology 2016; 239: 379 doi: 10.1007/164_2016_104
|
4 |
Xiao-yan GUO, Lei Dong, Mei LIU, Bin QIN. The distribution of motilin receptor in the amygdala of rats and its role in migrating myoelectric complex. Journal of Medical Colleges of PLA 2007; 22(6): 329 doi: 10.1016/S1000-1948(08)60013-1
|
5 |
Gareth J. Sanger. Why is motilin active in some studies with mice, rats, and guinea pigs, but not in others? Implications for functional variability among rodents. Pharmacology Research & Perspectives 2022; 10(2) doi: 10.1002/prp2.900
|
6 |
G. E. Gutierrez, D. Lalka, I. R. Garrett, G. Rossini, G. R. Mundy. Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations. Osteoporosis International 2006; 17(7): 1033 doi: 10.1007/s00198-006-0079-0
|